Global bone growth stimulator market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to the growing geriatric population along with the increasing incidences of accidental injuries along with bone disorders across the globe. Additionally, the rising prevalence of arthritis, diabetes-like diseases, and other medical conditions like obesity, vascular diseases, renal disorder and increasing demand for minimally invasive and non-invasive surgical treatments are the major factors driving the growth of the market over the years. Additionally, growing awareness about bone growth stimulators and procedural benefits provided by bone growth stimulators for the treatment of bone fracture and orthopedic diseases is further boosting the market growth during the forecast period. Besides, growing technological advancement in bone growth stimulators and the growing adoption rate for bone growth stimulators by patients and healthcare providers are major factors boosting the market’s growth over the years. Bone growth stimulators work by delivering energy to the site of the injury, which stimulates bone cells to grow and multiply. This process accelerates the healing of the injured bone, reducing the time required for recovery and decreasing the risk of complications such as infections and deformities. Bone growth stimulators have a wide range of applications in orthopedic medicine. They are commonly used in the treatment of non-union fractures, where the bone fails to heal properly after an injury. They are also used in spinal fusions, where two or more vertebrae are fused together to treat conditions such as degenerative disc disease, spinal stenosis, and herniated discs. Many bone growth stimulators are non-invasive and can be used externally without the need for surgery or implants. Studies have shown that bone growth stimulators can be effective in promoting bone healing and growth, particularly in cases of delayed or non-union fractures. Bone growth stimulators can help accelerate the healing process, reducing the amount of time required for bone to heal and reducing the risk of complications. Compared to surgical interventions, bone growth stimulators are often more cost-effective, making them a good option for patients and healthcare systems. Many bone growth stimulators are portable and can be used at home, allowing patients to continue their daily activities while undergoing treatment.
Growing Prevalence of Bone Disorders
More than 8.9 million fractures annually happen and affect around 75 million people in the U.S.
Growing research and development activities
For instance, in March 2016, Bioventus LLC launched its ultrasound bone healing stimulator system.
Recent Development
- In 2020, Orthofix launched its PhysioStim bone growth stimulator. The device uses low-intensity ultrasound technology to stimulate bone growth and is designed to treat non-healing fractures.
- In 2019, Zimmer Biomet launched the EBI Bone Healing System, a non-invasive device that uses pulsed electromagnetic fields to promote bone growth. The device is designed to treat fractures and promote bone healing after spinal fusion surgery.
- In 2018, Ossatec launched the Ossatec Stratos, a portable bone growth stimulator that uses low-intensity pulsed ultrasound technology to promote bone healing. The device is designed to be used at home and is intended to treat fractures and promote bone healing after surgery.
- In August 2021, Bioventus announced that it had received FDA approval for its newest bone growth stimulator, the Exogen X2. This device is designed to promote bone healing in fractures and non-unions, and it features a new, intuitive interface and improved battery life.
- In June 2021, Orthofix announced that it had launched a new version of its Spinal-Stim bone growth stimulator. The Spinal-Stim with Smart-Start technology is designed to automatically detect when it is properly placed on the patient's skin and to begin treatment without any manual adjustments.
- In May 2021, Stryker announced that it had received FDA clearance for its new bone growth stimulator, the BoneScalpel Ultrasonic System. This device uses ultrasonic energy to cut and remove bone tissue, and it is designed to be more precise and efficient than traditional surgical tools.
Market Segmentation
Global bone growth stimulator market can be segmented by type, application, end-user, and region. Based on type, the market can be segmented into External Bone Growth Stimulators, Ultrasonic Bone Growth Stimulators, and Implanted Bone Growth Stimulators. Based on application, the market can be grouped into Spinal Fusion Surgeries, Delayed Union, and Non-union Bone Fractures, Oral and Maxillofacial Surgeries, and Others. Based on end users, the market can be segmented into Hospital and Ambulatory Surgery Centers, Home Care Settings, and Academic and Research Institutes. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among these different countries, the United States dominated the global bone growth stimulator market on account of the growing demand for minimally invasive surgeries with low costs for the treatment of bone-related diseases.
Market Players
Colfax Corporation., Arthrex., Essex Woodlands Healthcare Partners., Isto Biologics., JOHNSON and JOHNSON., Medtronic Plc., Orthofix Medical Inc., Stryker Corporation., Terumo Corporation, Zimmer Biomet Holdings., Manamed Inc., Theragen Etex Co. Ltd. are some of the leading players operating in the Global Bone Growth Stimulators Market.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, and CAGR for 2018-2021 and 2023-2028 |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | · By Type · By Application · By End User · By Region |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
Key companies profiled | Colfax Corporation., Arthrex., Essex Woodlands Healthcare Partners., Isto Biologics., JOHNSON and JOHNSON., Medtronic Plc., Orthofix Medical Inc., Stryker Corporation., Terumo Corporation, Zimmer Biomet Holdings., Manamed Inc., Theragen Etex Co. Ltd. |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |